Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non–small cell lung cancer
Authors:
- Mehrdad RakaeeMRMehrdad Rakaee
- Thomas K. KilvaerTKThomas K. Kilvaer
- Stig Manfred DalenSDStig Manfred Dalen
- Elin RichardsenERElin Richardsen
- Erna-Elise PaulsenEPErna-Elise Paulsen
- Sigurd M. HaldSHSigurd M. Hald
- Samer Al-SaadSASamer Al-Saad
- Sigve AndersenSASigve Andersen
- Tom DonnemTDTom Donnem
- Roy M. BremnesRBRoy M. Bremnes
- Lill-Tove BusundLBLill-Tove Busund
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 79, 188-198
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The immune contexture in human tumours: impact on clinical outcomeNature Reviews Cancer, 2012
- Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung CancerJournal of Surgical Research, 2011
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to ChemotherapyCancer Research, 2011
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal CancerJournal of Clinical Oncology, 2009
- Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung NeoplasmsThe Annals of Thoracic Surgery, 2009
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid StructuresJournal of Clinical Oncology, 2008
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung CancerClinical Cancer Research, 2008
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- REporting recommendations for tumor MARKer prognostic studies (REMARK)Breast Cancer Research and Treatment, 2006